| PACKAGING TYPE: | 10x10 Alu-alu ( 10 Strip In 1 Box ) |
| COMPOSITION: | Telmisartan & Chlorthalidone |
| FORMULATION: | Tablet |
| Description: | TELOSAF-CT 80/12.5 Tablet is a combination of Telmisartan 80mg (an angiotensin II receptor blocker – ARB) and Chlorthalidone 12.5mg (a thiazide-like diuretic), indicated for the management of hypertension (high blood pressure). Telmisartan works by relaxing and widening blood vessels, while Chlorthalidone promotes the elimination of excess salt and water. This higher-strength combination is suitable for patients requiring more intensive blood pressure control and long-term cardiovascular risk reduction. |
| Side Effects: | Common side effects may include: Dizziness Weakness Increased urination Electrolyte imbalance Fatigue Serious (rare) side effects: Severe hypotension Kidney function impairment High uric acid levels Severe electrolyte disturbances |
| How to Use: | Take the tablet as prescribed by your doctor Usually taken once daily, preferably in the morning Swallow whole with water; can be taken with or without food Take regularly at the same time each day Follow lifestyle changes such as low-salt diet and exercise |
| Precaution: | Regular monitoring of blood pressure, kidney function, and electrolytes is required Use cautiously in patients with kidney or liver disease Maintain proper hydration Avoid potassium supplements unless advised Not recommended during pregnancy Inform doctor about other medications |
| Product Benefits: | Provides stronger control of high blood pressure Dual-action therapy (ARB + diuretic) for enhanced effectiveness Reduces risk of heart attack, stroke, and cardiovascular events Helps remove excess fluid and sodium from the body Offers long-lasting 24- |
Frequently Asked Questions
It is used for treating high blood pressure, especially in patients needing stronger BP control.
It contains a higher dose of Telmisartan (80mg) for enhanced antihypertensive effect.
It is usually taken once daily, preferably in the morning.




















